Structure

Physi-Chem Properties

Molecular Weight:  536.1
Volume:  503.975
LogP:  4.751
LogD:  2.358
LogS:  -3.686
# Rotatable Bonds:  6
TPSA:  189.26
# H-Bond Aceptor:  12
# H-Bond Donor:  5
# Rings:  5
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.122
Synthetic Accessibility Score:  3.451
Fsp3:  0.111
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  2
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.345
MDCK Permeability:  1.4457376892096363e-05
Pgp-inhibitor:  0.993
Pgp-substrate:  0.117
Human Intestinal Absorption (HIA):  0.857
20% Bioavailability (F20%):  0.185
30% Bioavailability (F30%):  0.996

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.001
Plasma Protein Binding (PPB):  82.83255004882812%
Volume Distribution (VD):  0.419
Pgp-substrate:  47.809898376464844%

ADMET: Metabolism

CYP1A2-inhibitor:  0.313
CYP1A2-substrate:  0.953
CYP2C19-inhibitor:  0.047
CYP2C19-substrate:  0.061
CYP2C9-inhibitor:  0.749
CYP2C9-substrate:  0.687
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.25
CYP3A4-inhibitor:  0.066
CYP3A4-substrate:  0.051

ADMET: Excretion

Clearance (CL):  5.958
Half-life (T1/2):  0.831

ADMET: Toxicity

hERG Blockers:  0.037
Human Hepatotoxicity (H-HT):  0.778
Drug-inuced Liver Injury (DILI):  0.989
AMES Toxicity:  0.207
Rat Oral Acute Toxicity:  0.041
Maximum Recommended Daily Dose:  0.822
Skin Sensitization:  0.903
Carcinogencity:  0.043
Eye Corrosion:  0.003
Eye Irritation:  0.718
Respiratory Toxicity:  0.035

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC295436

Natural Product ID:  NPC295436
Common Name*:   Alpha-Rubromycin
IUPAC Name:   methyl 7,8-dihydroxy-6-[2-(8-hydroxy-5,7-dimethoxy-4,9-dioxobenzo[f][1]benzofuran-2-yl)ethyl]-1-oxoisochromene-3-carboxylate
Synonyms:  
Standard InCHIKey:  LQNGOIZVRFNQLO-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C27H20O12/c1-35-14-9-15(36-2)22(30)19-18(14)21(29)13-8-12(38-25(13)24(19)32)5-4-10-6-11-7-16(26(33)37-3)39-27(34)17(11)23(31)20(10)28/h6-9,28,30-31H,4-5H2,1-3H3
SMILES:  COc1cc(c(c2c1C(=O)c1cc(CCc3cc4cc(C(=O)OC)oc(=O)c4c(c3O)O)oc1C2=O)O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3347655
PubChem CID:   5378308
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001634] Naphthofurans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4378 Uvariastrum zenkeri Species Annonaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO12747 Peronia verruculata Species Onchidiidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT144 Individual Protein Telomerase reverse transcriptase Homo sapiens IC50 > 200000.0 nM PMID[486341]
NPT81 Cell Line A549 Homo sapiens EC50 > 100000.0 nM PMID[486342]
NPT306 Cell Line PC-3 Homo sapiens EC50 > 100000.0 nM PMID[486342]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 3.0 ug.mL-1 PMID[486342]
NPT729 Organism Micrococcus luteus Micrococcus luteus MIC = 1.5 ug.mL-1 PMID[486342]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 0.4 ug.mL-1 PMID[486342]
NPT5246 Organism Mycobacterium aurum Mycobacterium aurum MIC > 24.0 ug.mL-1 PMID[486342]
NPT19 Organism Escherichia coli Escherichia coli MIC > 24.0 ug.mL-1 PMID[486342]
NPT1190 Organism Salmonella enterica Salmonella enterica MIC > 24.0 ug.mL-1 PMID[486342]
NPT312 Organism Saccharomyces cerevisiae Saccharomyces cerevisiae MIC > 24.0 ug.mL-1 PMID[486342]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC295436 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9213 High Similarity NPC174486
0.9205 High Similarity NPC475996
0.9205 High Similarity NPC47883
0.92 High Similarity NPC207467
0.9195 High Similarity NPC245975
0.9191 High Similarity NPC158226
0.9143 High Similarity NPC8127
0.9143 High Similarity NPC49667
0.9133 High Similarity NPC109827
0.9133 High Similarity NPC124470
0.9101 High Similarity NPC71260
0.9096 High Similarity NPC265795
0.9091 High Similarity NPC77179
0.9091 High Similarity NPC297807
0.9091 High Similarity NPC98546
0.9091 High Similarity NPC23553
0.9075 High Similarity NPC163130
0.9075 High Similarity NPC165979
0.9075 High Similarity NPC49487
0.9075 High Similarity NPC99613
0.9045 High Similarity NPC471842
0.9045 High Similarity NPC240508
0.9045 High Similarity NPC228209
0.904 High Similarity NPC473785
0.9029 High Similarity NPC82217
0.9029 High Similarity NPC65885
0.9029 High Similarity NPC216842
0.9029 High Similarity NPC476640
0.9023 High Similarity NPC28042
0.9 High Similarity NPC248315
0.8983 High Similarity NPC221820
0.8977 High Similarity NPC289244
0.8977 High Similarity NPC287243
0.8971 High Similarity NPC54098
0.8971 High Similarity NPC230619
0.8966 High Similarity NPC280493
0.8962 High Similarity NPC314020
0.896 High Similarity NPC29160
0.8956 High Similarity NPC60848
0.8944 High Similarity NPC226725
0.8939 High Similarity NPC8927
0.8939 High Similarity NPC182693
0.8939 High Similarity NPC246153
0.8933 High Similarity NPC476273
0.8927 High Similarity NPC24258
0.8927 High Similarity NPC471841
0.8927 High Similarity NPC164384
0.892 High Similarity NPC261471
0.892 High Similarity NPC30550
0.892 High Similarity NPC37606
0.892 High Similarity NPC277510
0.8914 High Similarity NPC218533
0.8914 High Similarity NPC78830
0.8914 High Similarity NPC476641
0.8908 High Similarity NPC95715
0.8908 High Similarity NPC234331
0.8895 High Similarity NPC240808
0.8889 High Similarity NPC154527
0.8876 High Similarity NPC246877
0.887 High Similarity NPC227906
0.8857 High Similarity NPC247136
0.8857 High Similarity NPC202470
0.8844 High Similarity NPC270837
0.8844 High Similarity NPC133065
0.8814 High Similarity NPC310794
0.8814 High Similarity NPC117450
0.8807 High Similarity NPC72696
0.88 High Similarity NPC76647
0.88 High Similarity NPC50394
0.88 High Similarity NPC86477
0.88 High Similarity NPC470704
0.8793 High Similarity NPC39306
0.8793 High Similarity NPC45449
0.8793 High Similarity NPC36320
0.8793 High Similarity NPC29411
0.8786 High Similarity NPC108767
0.8786 High Similarity NPC294965
0.8779 High Similarity NPC246478
0.8779 High Similarity NPC84571
0.8778 High Similarity NPC97523
0.8764 High Similarity NPC139350
0.8757 High Similarity NPC247964
0.8757 High Similarity NPC473113
0.8743 High Similarity NPC37870
0.8743 High Similarity NPC30027
0.8736 High Similarity NPC474350
0.8736 High Similarity NPC263092
0.8736 High Similarity NPC236132
0.8736 High Similarity NPC1755
0.8736 High Similarity NPC1706
0.8736 High Similarity NPC470459
0.8736 High Similarity NPC39305
0.8736 High Similarity NPC59295
0.8736 High Similarity NPC89131
0.8728 High Similarity NPC66288
0.8728 High Similarity NPC311740
0.8728 High Similarity NPC258331
0.8722 High Similarity NPC104682
0.8722 High Similarity NPC113446
0.8715 High Similarity NPC216307
0.8708 High Similarity NPC233956
0.8708 High Similarity NPC149846
0.8708 High Similarity NPC473834
0.8701 High Similarity NPC17219
0.8693 High Similarity NPC126204
0.8693 High Similarity NPC247973
0.8693 High Similarity NPC107009
0.8686 High Similarity NPC8070
0.8686 High Similarity NPC470457
0.8686 High Similarity NPC326520
0.8686 High Similarity NPC37183
0.8686 High Similarity NPC472450
0.8686 High Similarity NPC26386
0.8686 High Similarity NPC275780
0.8686 High Similarity NPC239752
0.8681 High Similarity NPC476170
0.8678 High Similarity NPC238995
0.8678 High Similarity NPC272722
0.8678 High Similarity NPC81679
0.8678 High Similarity NPC312056
0.8678 High Similarity NPC84515
0.8674 High Similarity NPC208069
0.8671 High Similarity NPC14353
0.8671 High Similarity NPC56085
0.8671 High Similarity NPC243701
0.8671 High Similarity NPC228785
0.8671 High Similarity NPC130955
0.8663 High Similarity NPC7973
0.8663 High Similarity NPC199463
0.8663 High Similarity NPC78302
0.8663 High Similarity NPC472438
0.8663 High Similarity NPC29841
0.8663 High Similarity NPC235215
0.8663 High Similarity NPC37543
0.8663 High Similarity NPC263483
0.8659 High Similarity NPC99591
0.8652 High Similarity NPC174700
0.8652 High Similarity NPC28589
0.8652 High Similarity NPC248593
0.8636 High Similarity NPC39091
0.8636 High Similarity NPC277480
0.8636 High Similarity NPC472452
0.8636 High Similarity NPC170245
0.8636 High Similarity NPC470462
0.8629 High Similarity NPC300984
0.8629 High Similarity NPC236521
0.8629 High Similarity NPC189473
0.8629 High Similarity NPC207690
0.8629 High Similarity NPC477689
0.8629 High Similarity NPC248638
0.8629 High Similarity NPC23298
0.8629 High Similarity NPC41301
0.8629 High Similarity NPC152659
0.8626 High Similarity NPC475656
0.8626 High Similarity NPC475148
0.8621 High Similarity NPC188486
0.8621 High Similarity NPC40491
0.8621 High Similarity NPC278052
0.8621 High Similarity NPC61010
0.8619 High Similarity NPC183843
0.8619 High Similarity NPC212290
0.8613 High Similarity NPC105242
0.8613 High Similarity NPC25495
0.8613 High Similarity NPC100123
0.8613 High Similarity NPC261004
0.8613 High Similarity NPC18772
0.8613 High Similarity NPC130894
0.8613 High Similarity NPC4481
0.8613 High Similarity NPC152166
0.8613 High Similarity NPC143828
0.8613 High Similarity NPC300943
0.8613 High Similarity NPC176300
0.8613 High Similarity NPC253634
0.8613 High Similarity NPC9609
0.8613 High Similarity NPC22472
0.8613 High Similarity NPC204854
0.8613 High Similarity NPC195832
0.8613 High Similarity NPC19687
0.8613 High Similarity NPC196879
0.8613 High Similarity NPC7846
0.8613 High Similarity NPC288669
0.8613 High Similarity NPC18607
0.8613 High Similarity NPC45846
0.8613 High Similarity NPC115798
0.8613 High Similarity NPC191459
0.8613 High Similarity NPC193842
0.8611 High Similarity NPC107244
0.8611 High Similarity NPC156955
0.8605 High Similarity NPC5379
0.8605 High Similarity NPC14561
0.8605 High Similarity NPC200388
0.8605 High Similarity NPC100916
0.8605 High Similarity NPC55619
0.8605 High Similarity NPC77807
0.8605 High Similarity NPC268161
0.8605 High Similarity NPC474520
0.8603 High Similarity NPC181523
0.8596 High Similarity NPC246716
0.8596 High Similarity NPC20543
0.8596 High Similarity NPC102277

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC295436 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8678 High Similarity NPD6232 Discontinued
0.8636 High Similarity NPD7473 Discontinued
0.8436 Intermediate Similarity NPD5844 Phase 1
0.8391 Intermediate Similarity NPD3882 Suspended
0.8382 Intermediate Similarity NPD2801 Approved
0.8352 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD3817 Phase 2
0.8305 Intermediate Similarity NPD1247 Approved
0.8286 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8268 Intermediate Similarity NPD6166 Phase 2
0.8268 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8268 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8177 Intermediate Similarity NPD3818 Discontinued
0.8146 Intermediate Similarity NPD5494 Approved
0.8136 Intermediate Similarity NPD7075 Discontinued
0.8111 Intermediate Similarity NPD3926 Phase 2
0.8095 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.809 Intermediate Similarity NPD919 Approved
0.8085 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8068 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8068 Intermediate Similarity NPD1465 Phase 2
0.8057 Intermediate Similarity NPD7411 Suspended
0.8046 Intermediate Similarity NPD3226 Approved
0.8043 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8034 Intermediate Similarity NPD3749 Approved
0.8023 Intermediate Similarity NPD5402 Approved
0.8011 Intermediate Similarity NPD6801 Discontinued
0.8011 Intermediate Similarity NPD1934 Approved
0.8 Intermediate Similarity NPD6559 Discontinued
0.8 Intermediate Similarity NPD6959 Discontinued
0.7977 Intermediate Similarity NPD1512 Approved
0.7966 Intermediate Similarity NPD7819 Suspended
0.7966 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7946 Intermediate Similarity NPD6797 Phase 2
0.7919 Intermediate Similarity NPD2534 Approved
0.7919 Intermediate Similarity NPD2533 Approved
0.7919 Intermediate Similarity NPD2532 Approved
0.7919 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7903 Intermediate Similarity NPD7251 Discontinued
0.7898 Intermediate Similarity NPD6599 Discontinued
0.7869 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7861 Intermediate Similarity NPD1511 Approved
0.7861 Intermediate Similarity NPD7808 Phase 3
0.7838 Intermediate Similarity NPD7054 Approved
0.7831 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7821 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7816 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7814 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7797 Intermediate Similarity NPD4380 Phase 2
0.7796 Intermediate Similarity NPD7472 Approved
0.7796 Intermediate Similarity NPD7074 Phase 3
0.779 Intermediate Similarity NPD6234 Discontinued
0.7789 Intermediate Similarity NPD8434 Phase 2
0.7759 Intermediate Similarity NPD6799 Approved
0.7742 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD7435 Discontinued
0.7637 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD5403 Approved
0.7627 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7611 Intermediate Similarity NPD37 Approved
0.7609 Intermediate Similarity NPD7199 Phase 2
0.7594 Intermediate Similarity NPD7228 Approved
0.7586 Intermediate Similarity NPD3750 Approved
0.7582 Intermediate Similarity NPD4965 Approved
0.7582 Intermediate Similarity NPD4966 Approved
0.7582 Intermediate Similarity NPD4967 Phase 2
0.7582 Intermediate Similarity NPD7768 Phase 2
0.7572 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7539 Intermediate Similarity NPD8313 Approved
0.7539 Intermediate Similarity NPD8312 Approved
0.7538 Intermediate Similarity NPD6780 Approved
0.7538 Intermediate Similarity NPD6776 Approved
0.7538 Intermediate Similarity NPD6781 Approved
0.7538 Intermediate Similarity NPD6782 Approved
0.7538 Intermediate Similarity NPD6779 Approved
0.7538 Intermediate Similarity NPD6777 Approved
0.7538 Intermediate Similarity NPD6778 Approved
0.7529 Intermediate Similarity NPD1243 Approved
0.7529 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7528 Intermediate Similarity NPD920 Approved
0.7514 Intermediate Similarity NPD5401 Approved
0.7514 Intermediate Similarity NPD1471 Phase 3
0.7513 Intermediate Similarity NPD8150 Discontinued
0.75 Intermediate Similarity NPD8151 Discontinued
0.75 Intermediate Similarity NPD3751 Discontinued
0.75 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7463 Intermediate Similarity NPD7874 Approved
0.7463 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD7390 Discontinued
0.7457 Intermediate Similarity NPD2935 Discontinued
0.7429 Intermediate Similarity NPD2800 Approved
0.7416 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD2344 Approved
0.7414 Intermediate Similarity NPD2346 Discontinued
0.7405 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD7870 Phase 2
0.7389 Intermediate Similarity NPD7871 Phase 2
0.7387 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.738 Intermediate Similarity NPD5710 Approved
0.738 Intermediate Similarity NPD5711 Approved
0.7363 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7345 Intermediate Similarity NPD6190 Approved
0.734 Intermediate Similarity NPD7697 Approved
0.734 Intermediate Similarity NPD7696 Phase 3
0.734 Intermediate Similarity NPD7698 Approved
0.7318 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7316 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD3748 Approved
0.7299 Intermediate Similarity NPD1510 Phase 2
0.7287 Intermediate Similarity NPD3787 Discontinued
0.7286 Intermediate Similarity NPD6534 Approved
0.7286 Intermediate Similarity NPD6535 Approved
0.7283 Intermediate Similarity NPD1607 Approved
0.7282 Intermediate Similarity NPD7701 Phase 2
0.7273 Intermediate Similarity NPD1549 Phase 2
0.7263 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.726 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.726 Intermediate Similarity NPD7783 Phase 2
0.7257 Intermediate Similarity NPD2796 Approved
0.7247 Intermediate Similarity NPD2309 Approved
0.7225 Intermediate Similarity NPD230 Phase 1
0.7216 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD5953 Discontinued
0.72 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7196 Intermediate Similarity NPD7229 Phase 3
0.7196 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7191 Intermediate Similarity NPD4628 Phase 3
0.7178 Intermediate Similarity NPD7699 Phase 2
0.7178 Intermediate Similarity NPD7700 Phase 2
0.7177 Intermediate Similarity NPD7801 Approved
0.7172 Intermediate Similarity NPD4287 Approved
0.7168 Intermediate Similarity NPD1240 Approved
0.7168 Intermediate Similarity NPD943 Approved
0.7165 Intermediate Similarity NPD7240 Approved
0.7159 Intermediate Similarity NPD5404 Approved
0.7159 Intermediate Similarity NPD5405 Approved
0.7159 Intermediate Similarity NPD5408 Approved
0.7159 Intermediate Similarity NPD5406 Approved
0.7159 Intermediate Similarity NPD1551 Phase 2
0.7158 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7136 Intermediate Similarity NPD8319 Approved
0.7136 Intermediate Similarity NPD8320 Phase 1
0.7126 Intermediate Similarity NPD447 Suspended
0.7104 Intermediate Similarity NPD1653 Approved
0.7102 Intermediate Similarity NPD2799 Discontinued
0.7095 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7077 Intermediate Similarity NPD7685 Pre-registration
0.7059 Intermediate Similarity NPD8285 Discontinued
0.7052 Intermediate Similarity NPD2313 Discontinued
0.7039 Intermediate Similarity NPD6823 Phase 2
0.7037 Intermediate Similarity NPD7907 Approved
0.7033 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7031 Intermediate Similarity NPD2403 Approved
0.7022 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.701 Intermediate Similarity NPD7286 Phase 2
0.7 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7003 Approved
0.6973 Remote Similarity NPD7458 Discontinued
0.6971 Remote Similarity NPD4060 Phase 1
0.697 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6966 Remote Similarity NPD6099 Approved
0.6966 Remote Similarity NPD6100 Approved
0.6963 Remote Similarity NPD8127 Discontinued
0.6959 Remote Similarity NPD7177 Discontinued
0.6954 Remote Similarity NPD3764 Approved
0.6954 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6927 Remote Similarity NPD6808 Phase 2
0.6923 Remote Similarity NPD7680 Approved
0.6914 Remote Similarity NPD6233 Phase 2
0.6908 Remote Similarity NPD2494 Approved
0.6908 Remote Similarity NPD2493 Approved
0.6897 Remote Similarity NPD6212 Phase 3
0.6897 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6897 Remote Similarity NPD6213 Phase 3
0.6895 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6893 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6893 Remote Similarity NPD6651 Approved
0.6879 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6869 Remote Similarity NPD7549 Discontinued
0.6866 Remote Similarity NPD4111 Phase 1
0.6866 Remote Similarity NPD4665 Approved
0.6857 Remote Similarity NPD1699 Clinical (unspecified phase)
0.6857 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6857 Remote Similarity NPD6798 Discontinued
0.6857 Remote Similarity NPD3268 Approved
0.6857 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6839 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6836 Remote Similarity NPD1933 Approved
0.6827 Remote Similarity NPD3450 Approved
0.6827 Remote Similarity NPD3452 Approved
0.6811 Remote Similarity NPD6273 Approved
0.681 Remote Similarity NPD4582 Approved
0.681 Remote Similarity NPD4583 Approved
0.6804 Remote Similarity NPD5242 Approved
0.6789 Remote Similarity NPD4288 Approved
0.6789 Remote Similarity NPD2296 Approved
0.6786 Remote Similarity NPD8067 Phase 3
0.6786 Remote Similarity NPD2163 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data